Pasar al contenido principal

DESARROLLO DE NUEVOS FARMACOS ANTIPARASITARIOS DIRIGIDOS A DUPLEX Y CUADRUPLEX DE ADN

PID2022-136438OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antitumor Activity of Symmetrical Selenoesters in Doxorubicin Resistant Breast Cancer

  • Racz, B.
  • Kristof, E.
  • Kincses, A.
  • Domínguez-Álvarez, Enrique
  • Spengler, G.
Background/Aim: Previously, selenocompounds (Se-compounds) and in particular selenoesters have shown promising anticancer activities. Since molecular symmetry can enhance the anticancer activity, nine symmetrical selenoesters (Se-esters) have been designed as novel, potentially active anticancer agents against doxorubicin resistant breast cancer cells. Materials and Methods: To assess the biological effects of the symmetrical Se-esters, the antiproliferative activity was determined on sensitive MCF-7 and doxorubicin resistant KCR breast cancer cell lines. The interaction of the derivatives with doxorubicin was evaluated by checkerboard combination assay on KCR cells. Furthermore, apoptosis induction and ATPase activity in the presence of Se-esters were also determined on KCR cells. Results: The symmetrical derivatives showed a noteworthy antiproliferative activity, with two of them showing IC values in submicromolar concentration on MCF-7 cells. In addition, some derivatives showed selectivity towards the resistant KCR cells. The combination of most of them with doxorubicin resulted in synergistic interaction, and all Se-esters could induce early and late apoptosis in KCR cells. Finally, the compounds affected the ATPase activity of ABCB1 (P-gp). Conclusion: The symmetrical Se-esters showed potent anticancer activity, according to in vitro tests. Further research needs to be performed to obtain similar derivatives with a better activity and selectivity, and to ascertain the potential application of these Se-containing compounds using in vivo systems., The study was supported by the following organizations and grants: Szeged Foundation for Cancer Research (Szegedi Rákkutatásért Alapítvány), Grant PID2022-136438OB-I00 funded by MCIN/AEI/ 10.13039/501100011033, European Regional Development Fund - "A way of making Europe" by the European Union. G.S. was supported by the János Bolyai Research Scholarship (BO/00158/22/5) of the Hungarian Academy of Sciences, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Formation, identification, and occurrence of the furan-containing β-carboline flazin derived from l-tryptophan and carbohydrates

  • Herraiz Tomico, Tomás
  • Salgado, Antonio
β-Carbolines (βCs) are bioactive indole alkaloids found in foods and in vivo. This work describes the identification, formation, and occurrence in foods of the βC with a furan moiety flazin (1-[5-(hydroxymethyl)furan-2-yl]-9H-pyrido[3,4-b]indole-3-carboxylic acid). Flazin was formed by the reaction of l-tryptophan with 3-deoxyglucosone but not with 5-hydroxymethylfurfural. Its formation was favored in acidic conditions and heating (70–110 °C). The proposed mechanism of formation occurs through the formation of intermediates 3,4-dihydro-β-carboline-3-carboxylic acid (imines), followed by the oxidation to C═O in the carbohydrate chain and aromatization to βC ring with subsequent dehydration steps and cyclization to afford the furan moiety. Flazin is generated in the reactions of tryptophan with carbohydrates. Its formation from fructose was higher than from glucose, whereas sucrose gave flazin under acidic conditions and heating owing to hydrolysis. Flazin was identified in foods by HPLC-MS, and its content was determined by HPLC-fluorescence. It occurred in numerous processed foods, such as tomato products, including crushed tomato puree, fried tomato, ketchup, tomato juices, and jams, but also in soy sauce, beer, balsamic vinegar, fruit juices, dried fruits, fried onions, and honey. Their concentrations ranged from not detected to 22.3 μg/mL, with the highest mean levels found in tomato concentrate (13.9 μg/g) and soy sauce (9.4 μg/mL). Flazin was formed during the heating process, as shown in fresh tomato juice and crushed tomatoes. These results indicate that flazin is widely present in foods and is daily uptaken in the diet., The authors thank the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) for funding through the projects PID2021-127833OB-I00 (co-funded by the European Regional Development Fund, ERDF, “A way to build Europe”), and PDC2022-133269-I00 and PID2022-136438OB-I00 (funded by Recovery and Resilience Facility, RRF, NexGenerationEU). The authors thank Adriana Peña (AP) and Haroll Mateo Feliz (HMF) for HPLC analyses and Laura Peláez (IQM-CSIC) for HPLC-MS analyses. AP and HMF were recipients of the Garantía Juvenil contract (Comunidad de Madrid and Fondo Social Europeo-YEI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lactobacillus species do not produce 1-acetyl-β-carboline

  • Herraiz Tomico, Tomás
  • Sánchez-Arroyo, Ana
  • De Las Rivas, Blanca
  • Muñoz, Rosario
The authors thank the Agencia Estatal de Investigación (MCIN/AEI/https://doi.org/10.13039/501100011033) for funding through the projects PID-2021-123291OB-I00, PID-2021-127833OB-I00 (co-funded by the European Regional Development Fund. ERDF, “A way to build Europe”), and PID2022-136438OB-I00 (funded by Recovery and Resilience Facility, RRF, NextGenerationEU)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Crystal structure of the HMGA AT-hook 1 domain bound to the minor groove of AT-rich DNA and inhibition by antikinetoplastid drugs

  • Nué Martínez, J. Jonathan
  • Maturana, M.
  • Lagartera, Laura
  • Rodríguez-Gutiérrez, J. A.
  • Boer, R.
  • Campos, J. L.
  • Saperas, N.
  • Dardonville, Christophe
High mobility group (HMG) proteins are intrinsically disordered nuclear non-histone chromosomal proteins that play an essential role in many biological processes by regulating the expression of numerous genes in eukaryote cells. HMGA proteins contain three DNA binding motifs, the “AT-hooks”, that bind preferentially to AT-rich sequences in the minor groove of B-form DNA. Understanding the interactions of AT-hook domains with DNA is very relevant from a medical point of view because HMGA proteins are involved in different conditions including cancer and parasitic diseases. We present here the first crystal structure (1.40 Å resolution) of the HMGA AT-hook 1 domain, bound to the minor groove of AT-rich DNA. In contrast to AT-hook 3 which bends DNA and shows a larger minor groove widening, AT-hook 1 binds neighbouring DNA molecules and displays moderate widening of DNA upon binding. The binding affinity and thermodynamics of binding were studied in solution with surface plasmon resonance (SPR)-biosensor and isothermal titration calorimetry (ITC) experiments. AT-hook 1 forms an entropy-driven 2:1 complex with (TTAA)-containing DNA with relatively slow kinetics of association/dissociation. We show that N-phenylbenzamide-derived antikinetoplastid compounds (1–3) bind strongly and specifically to the minor groove of AT-DNA and compete with AT-hook 1 for binding. The central core of the molecule is the basis for the observed sequence selectivity of these compounds. These findings provide clues regarding a possible mode of action of DNA minor groove binding compounds that are relevant to major neglected tropical diseases such as leishmaniasis and trypanosomiasis., This study was funded by Generalitat de Catalunya (Grant: 2021SGR-01042) and by Agencia Estatal de Inves- tigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the “European Un- ion”, through the grants RTI2018-093940-B-I00, PID2022-136438OB-I00, PID2022-140302OB-I00, and PD- C2022−133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU). Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanostructured Lipid Carrier for Intracellular Delivery of a Bis(pyridine-2-carboxamidine) DNA Minor Groove Binder Active against Leishmania

  • Nué Martínez, J. Jonathan
  • Leo-Barriga, Marta
  • Herranz, Fernando
  • Koutsogiannis, Zisis
  • Denny, Paul W.
  • Ebiloma, Godwin U.
  • Dardonville, Christophe
  • González-Paredes, Ana
Two types of nanostructured lipid carrier (NLC) formulations of the antileishmanial DNA minor groove binding compound 4-(picolinimidamido)-N-(4-(picolinimidamido)phenyl)benzamide (1) were synthesized by the microemulsion method to evaluate their potential as a delivery system to intracellular forms of the Leishmania parasite. Compound 1-loaded NLC formulations, functionalized with folic acid (FA) or not, showed good colloidal stability both during storage and after dilution in biologically relevant media. The drug release, which was not pH dependent, occurred efficiently at 37 °C. Compound 1 and its NLC formulations displayed a good selectivity index (SI > 40) and were active in the submicromolar range against promastigotes and metacyclic promastigotes of Leishmania major and in the low micromolar range (∼2 μM) against intramacrophage amastigotes. However, they were inactive against Leishmania mexicana. This proof-of-concept study showed that compound 1 could be loaded effectively in NLC and FA-coated NLC whose size and anionic nature (i.e., FA-NLC) are favorable for uptake into macrophages. NLC functionalization with FA had a beneficial effect on the antileishmanial activity of 1 compared with noncoated NLC formulations, which resulted in an increase in selectivity toward the parasite., This study was supported by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the “European Union”, under grants RTI2018-093940-B-I00, PID2022-136438OB-I00, and PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU) and Comunidad de Madrid (Spain) under “Atracción de Talento (Modalidad 1)” program (Reference 2019-T1/IND-12906)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selenocompounds as Potent Efflux Pump Inhibitors on Gram-positive Bacteria

  • Kincses, A.
  • Szemerédi, N.
  • Benito-Lama, Miguel
  • Dózsai, D.
  • Csonka, Á.
  • Domínguez-Álvarez, Enrique
  • Spengler, G.
In recent years, selenocompounds have gained increasing attention as potential anticancer and antibacterial agents. Several selenoderivatives have been confirmed to act as MDR efflux pump inhibitors, based on their in vitro results against the bacterial AcrAB-TolC system and the cancer MDR efflux pump P-glycoprotein. Efflux pumps can contribute directly or indirectly to the virulence of bacteria, as they can reduce the intracellular concentration of antibacterial substances by expelling them out of the cell. The present work aims to study the antibacterial and efflux pump inhibiting properties of four families of selenoesters, namely aspirin-selenoesters, phenone-selenoesters, hydroxy-selenoesters, and benzyl-selenoesters. The real-time ethidium bromide accumulation assay confirmed that these derivatives inhibited the efflux systems of methicillin-resistant Staphylococcus aureus (MRSA) without exerting any antibacterial effect. The relative expression of efflux pump gene of NorA transporter was also monitored in the presence of the most potent derivatives on reference S. aureus, finding that these derivatives could change the expression of the tested efflux pump gene. Regarding the anti-biofilm activity, aspirin-selenoesters, benzyl-selenoesters, and hydroxy-selenoesters could efficiently inhibit the biofilm production of the MRSA strain. It can be concluded that selenocompounds could act as efflux pump inhibitors, thus reducing the virulence of biofilm-producing bacteria., The study was supported by the Szeged Foundation for Cancer Research (Szegedi Rákkutatásért Alapítvány). This research was funded by the János Bolyai Research Scholarship of the Hungarian Academy of Sciences, grant number BO/00158/22/5(G.S.). N.S. was supported by the ÚNKP-21-3-SZTE-103 and A.K.was supported by the ÚNKP-23-4-SZTE-215 New National Excellence Program of the Ministry for Culture and Innovationfrom the source of the National Research, Development and Innovation Fund. Authors want to thank Agencia Estatal Consejo Superior de Investigaciones Científicas (State Agency Spanish National Research Council) for the travel grants (E.D.A.)funded within the iLINK project LINKA20285. Authors also thank the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) and “ERDF A way of making Europe”, by the European Union, through the grant PID2022-136438OB-I00(E.D.A.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Products of Selenite/Thiols Interaction Have Reducing Properties, Cleave Plasmid DNA and Decrease Rat Blood Pressure and Tension of Rat Mesenteric Artery

  • Grman, Marian
  • Balis, Peter
  • Berenyiova, Andrea
  • Svajdlenkova, Helena
  • Tomasova, Lenka
  • Cacanyiova, Sona
  • Rostakova, Zuzana
  • Waczulikova, Iveta
  • Chovanec, Miroslav
  • Domínguez-Álvarez, Enrique
  • Ondrias, Karol
  • Misak, Anton
Selenium compounds exert their antioxidant activity mostly when the selenium atom is incorporated into selenoproteins. In our work, we tested the possibility that selenite itself interacts with thiols to form active species that have reducing properties. Therefore, we studied the reduction of 2-(4-carboxyphenyl)-4,5-dihydro-4,4,5,5-tetramethyl-1H-imidazol-1-yloxy-3-oxide radical (•cPTIO), damage of plasmid DNA (pDNA), modulation of rat hemodynamic parameters and tension of isolated arteries induced by products of interaction of selenite with thiols. We found that the products of selenite interaction with thiols had significant reducing properties that could be attributed mainly to the selenide and that selenite had catalytic properties in the access of thiols. The potency of thiols to reduce •cPTIO in the interaction with selenite was cysteine > homocysteine > glutathione reduced > N-acetylcysteine. Thiol/selenite products cleaved pDNA, with superoxide dismutase enhancing these effects suggesting a positive involvement of superoxide anion in the process. The observed •cPTIO reduction and pDNA cleavage were significantly lower when selenomethionine was used instead of selenite. The products of glutathione/selenite interaction affected several hemodynamic parameters including rat blood pressure decrease. Notably, the products relaxed isolated mesenteric artery, which may explain the observed decrease in rat blood pressure. In conclusion, we found that the thiol/selenite interaction products exhibited significant reducing properties which can be used in further studies of the treatment of pathological conditions caused by oxidative stress. The results of decreased rat blood pressure and the tension of mesenteric artery may be perspective in studies focused on cardiovascular disease and their prevention., Open access funding provided by The Ministry of Education, Science, Research and Sport of the Slovak Republic in cooperation with Centre for Scientific and Technical Information of the Slovak Republic This research was funded by the Slovak Research and Development Agency, grant number APVV-19–0154 to K.O., APVV-22–0154 to P.B. and SK-BY-RD-19–0019 to I.W.; the Scientific Grant Agency of the Slovak Republic, grant number VEGA 2/0091/21 to A.M., VEGA 2/0066/23 to L.T. and VEGA 2/0023/22 to Z.R.; the European Union´s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement number 945478 supporting the study number 1368/03/02 to P.B.; the MCIN/AEI/https://doi. org/10.13039/501100011033, ERDF, A way of making Europe and by the European Union, grant number PID2022-136438OB-I00 to E.D-Á, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification, occurrence, and mechanism of formation of 1-acetyl-β-carbolines derived from l-tryptophan and methylglyoxal

  • Herraiz Tomico, Tomás
  • Salgado, Antonio
  • Peña, Adriana
β-Carbolines (βCs) are bioactive compounds present in foods and biological systems. This work describes the identification, occurrence, and mechanism of formation of 1-acetyl-β-carbolines (1-acetyl-βCs) that result from the reaction of l-tryptophan with the α-dicarbonyl compound methylglyoxal. Two β-carbolines are characterized as 1-acetyl-β-carboline (AβC) and 1-acetyl-β-carboline-3-carboxylic acid (AβC-COOH). Their formation was favored in acidic conditions and with increasing temperature, but 1-acetyl-βCs also formed in moderate temperatures and in a wide range of pH, including physiological conditions, and in human serum. The formation mechanism relies on tautomerism and cyclization to give 1-(1-hydroxyethyl)-3,4-dihydro-β-carboline-3-carboxylic acid intermediates followed by the oxidation of C1'-OH and aromatization to 1-acetyl-βCs. The formation of 1-acetyl-βCs took place in the reactions of fructose or glucose with tryptophan under heating and depended on the methylglyoxal released during carbohydrate degradation. Formation from carbohydrates increased at neutral or basic pH values as more methylglyoxal was released under those conditions. Thus, 1-acetyl-βCs could be advanced glycation end-products (AGEs). 1-Acetyl-βCs were identified and quantified for the first time in many foods. AβC ranged from undetectable to 250 ng/g with the highest amount detected in honey, bread, cookies, soy sauce, and coffee. On average, AβC-COOH generally appeared in lower concentrations than AβC but it ranged from undetectable to 323 ng/g with the highest levels found in soy sauce, honey, cookies, and fried bread. These results indicate that 1-acetyl-βCs could be relevant βCs in foods and in vivo., The authors thank the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) for funding through the projects PID2021-127833OB-I00 (cofunded by the European Regional Development Fund (ERDF), “A way to build Europe”), and PDC2022-133269-I00 and PID2022-136438OB-I00 (funded by Recovery and Resilience Facility, RRF, NextGenerationEU). The authors thank Laura Peláez (IQM-CSIC) for HPLC–MS analyses. AP was a recipient of a Garantía Juvenil contract (Comunidad de Madrid and Fondo Social Europeo-YEI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Uncovering the Unusual Inhibition Mechanism of a Trypanosome Alternative Oxidase Inhibitor Displaying Broad-Spectrum Activity against African Animal Trypanosomes

  • Ebiloma, Godwin U.
  • Balogun, Emmanuel O.
  • Arai, Natsumi
  • Otani, Momoka
  • Baldassarri, Cecilia
  • Alhejely, Amani
  • Cueto-Díaz, Eduardo J.
  • De Koning, Harry P.
  • Dardonville, Christophe
  • Shiba, Tomoo
The glucose-dependent respiration of bloodstream forms of the parasite Trypanosoma brucei depends on an unusual and essential mitochondrial electron-transport system, consisting of glycerol-3-phosphate dehydrogenase and the trypanosome alternative oxidase (TAO). We report here the discovery of an allosteric inhibitor of TAO that displays highly potent activity (EC50 values in the range 1-20 nM) against the important veterinary pathogens T. b. brucei, Trypanosoma evansi, Trypanosoma equiperdum, and Trypanosoma congolense, i.e., >5-fold greater potency than the standard drugs. The methylene-linked 2-methyl-4-hydroxybenzoate 2-pyridinyldiphenylphosphonium derivative (1) was the best inhibitor of recombinant TAO (IC50 = 1.3 nM) via a noncompetitive/allosteric mechanism (Ki = 3.46 nM). Remarkably, X-ray crystallography showed that 1 was bound to a site of TAO ∼25 Å from the catalytic pocket. Although 1 demonstrated good safety toward mammalian cells in vitro (selectivity index >2300), it did not fully clear parasitemia in experimental animals, attributable to a high hepatic clearance., This study received funding from the Japan Society for the Promotion of Science (JSPS) through a JSPS postdoctoral fellowship research grant (17F17420), and a Royal Society Grant (RGS\R2\222269) to G.U.E. The research is also funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/ 501100011033), and “ERDF A way of making Europe”, by the “European Union”, through the grants RTI2018-093940-B-I00, PID2022-136438OB-I00, and PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGener- ationEU). E.O.B. is a recipient of an Emerging Global Leader (K43) Award and is supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW012015. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development and Characterization of a New Oral Antileishmanial Bis(pyridine-2-Carboxamidine) Drug Through Innovative Dissolution Testing in Biorelevant Media Combined with Pharmacokinetic Studies

  • Laguna, Almudena
  • Martínez Alonso, Borja
  • Guarnizo Herrero, Víctor
  • Nué Martínez, J. Jonathan
  • Dardonville, Christophe
  • Torrado-Santiago, Santiago
  • Torrado Salmerón, Carlos
[Background/Objectives] Currently there are very few effective oral antileishmanial treatments. In this study we evaluated a new bis(pyridine-2-carboxamidine) antileishmanial drug (JNII40_base) and its hydrochloride salt (JNII40_HCl)., [Methods] The characterization studies performed allowed us to determine the crystallinity, hydration water, and presence of hydrogen bonds in these drugs. Different dissolution methods were employed to predict intestinal absorption. A high-performance liquid chromatography–mass spectrophotometry (HPLC-MS/MS) method was developed for the determination of JNII40 in plasma., [Results] Pharmacokinetic studies in rats of JNII40_base at 100 and 20 mg/kg, and JNII40_HCl at 20 mg/kg, showed a non-linear pharmacokinetic at high doses. An innovative biorelevant medium of phosphate buffer pH 6.8 with polysorbate 80 at 0.6% (w/v) showed high concentration values for JNII40_base at 30 min, which predicts good intestinal absorption. These results were consistent with the bioavailability data, which exhibited a significant (p < 0.05) increase in maximum plasma concentration (Cmax) and a slight delay in time to maximum (Tmax) compared to JNII40_HCl. Furthermore, the sustained release of JNII40_base in this biorelevant media was related to high plasma concentration values at 24 h (C24h) observed in bioavailability studies. These plasma concentrations of JNII40_base were above the half-maximal inhibitory concentration (IC50) against promastigote and amastigote forms of Leishmania donovani, which is indicative of effectiveness and should reduce the occurrence of drug resistance during treatments., [Conclusions] The bioavailability and pharmacokinetic data support the consideration of this drug for further in vivo studies as an oral antileishmanial treatment., This research was funded by the Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033), grant numbers PDC2022-133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU) and PID2022-136438OB-I00 (co-funded by the European Regional Development Fund, ERDF, “A way to build Europe”), and by the Complutense University of Madrid (Research Group 910939)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Organic Compounds with Biological Activity

  • Marć, Małgorzata Anna
  • Domínguez-Álvarez, Enrique
No new data were created or analyzed in this study. Data sharing is not applicable to this article., The Special Issue with the title ‘Organic Compounds with Biological Activity’ [1] was launched at the end 2022. It aimed to collect scientific articles submitted to the journal ‘Compounds’ that either explore the search of organic compounds with biological activity that can have applications in Medicine, Veterinary, Agriculture, and in the disinfection of tools, spaces, and surfaces, or review the biological activities or applications of chemical compounds in these fields.[...], Authors want to express their gratitude to the funding agencies Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033, E.D.-Á.; and PTA2022-022277-I, M.A.M) and to “ERDF A way of making Europe”, by the European Union, grant PID2022-136438OB-I00 (E.D.A.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discovery and SAR studies of antiviral 4-aminopiperidine derivatives active against SARS-CoV-2

  • Algar, Sergio
  • Bueno, Paula
  • Anatoliev-Dimitrov, Hristo
  • Medina, Jessy
  • Trifero, Valentina
  • Castro, Victoria
  • Garaigorta, Urtzi
  • Gastaminza, Pablo
  • Dardonville, Christophe
Supplementary data to this article can be found online at https://doi.org/10.1016/j.ejmech.2025.118475, Two related families of 4-aminopiperidine compounds active against SARS-CoV-2 in the micromolar range were discovered by screening the CSIC Chemical library. A medicinal chemistry programme was completed to optimize these series. Seventy-four derivatives of the early hits were synthesized which allowed to develop SAR studies and identify new hit compounds with low micromolar in vitro antiviral activity (EC90 < 2 μM) and improved selectivity indexes in A594-hACE2 cells (from 13- to >28). Compounds which were active against two coronaviruses (SARS-CoV-2 and HCoV-229E) were less effective against the unrelated vesicular stomatitis virus (VSV), suggesting certain selectivity for coronaviruses. Several hit compounds, which are cationic amphiphilic compounds with pKa values mostly >7.6 and > 9, were shown to induce phospholipidosis in A594-hACE2 cells. This suggests that the limited capacity of these molecules to prevent efficient viral propagation, as compared with Remdesivir, is possibly related to a mode of action that involves phospholipid metabolism., We acknowledge support from the “Global Health” Interdisciplinary Platform (PTI Salud Global) funded by the Consejo Superior de Investigaciones Científicas (CSIC), Spain, and by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033), through the grant PIE-RD-COVID-19 Ref. 202020E079, and “ERDF A way of making Europe”, by the “European Union”, through the grants PID2022-136438OB-I00, and PDC2022−133269-I00 (funded by the Recovery and Resilience Facility, RRF, NextGenerationEU). Paula Bueno is supported by PIPF2022/SAL-GL-25488 fellowship from Comunidad de Madrid, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kinetoplast-Directed Therapies: A Selective Mitochondrial Approach to Combat Leishmaniasis

  • Botero-Buitrago, Jenny A.
  • Cardozo-Muñoz, Juan Camilo
  • Cisneros, David
  • Santamaría-Aguirre, Javier
  • Torres, Koraima
  • Espuelas, Socorro
  • Carrión, Javier
  • Dardonville, Christophe
This article belongs to the Collection Drug Discovery and Development for Tropical Diseases (TDs), The leishmaniases are a group of neglected tropical diseases caused by kinetoplastid protozoa of the genus Leishmania, transmitted by phlebotomine sandflies. In the absence of a human vaccine, current chemotherapeutic options remain suboptimal due to limited target selectivity, high cost, restricted availability in endemic low-resource regions, and escalating parasite resistance. This review highlights recent advances in rational drug design directed at the kinetoplast—a distinctive mitochondrial organelle critical for parasite viability. Different targets (e.g., kDNA, G-quadruplex, topoisomerases) and innovative approaches employing mitochondrion-targeted small molecules are discussed, as well as ligand-functionalized nanoparticle delivery systems that can transport bioactive agents to the parasite’s mitochondrial microenvironment. These strategies highlight the kinetoplast’s strong translational relevance as a selective antileishmanial target. By exploiting its unique molecular machinery, these strategies may offer improved parasite selectivity, although potential mitochondrial liabilities in host cells must be carefully evaluated., Funding by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033) (Co-funded by European Regional Development Fund. ERDF, “A way to build Europe”, by the “European Union”), through the grants PID2020-114207RB-I00, PID2022-136438OB-I00 and PID2023-148406OB-I00, is gratefully acknowledged. JCM is supported by a PhD scholarship (PREP2022-000704) funded by Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033). David Cisneros is supported by a PhD scholarship (PIPF-2022SAL-GL-24344) from Comunidad de Madrid, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Bacteria from foods and gut microbiota produce methylglyoxal and this metabolite leads to the formation of bioactive 1-acetyl-β-carboline alkaloids

  • Herraiz Tomico, Tomás
  • Sánchez-Arroyo, Ana
  • De Las Rivas, Blanca
  • Landete, José María
  • Muñoz, Rosario
Methylglyoxal (MGO) is a highly reactive and toxic compound whereas 1-acetyl-β-carbolines (ACE-βCs) are bioactive alkaloids. These compounds were studied in cultures of bacteria from foods and human gut microbiota. Two ACE-βCs were identified as 1-acetyl-β-carboline (AβC) and 1-acetyl-β-carboline-3-carboxylic acid (AβC-COOH). Cultures containing ACE-βCs also contained MGO that was produced during bacterial growth. MGO produced by bacteria reacted spontaneously with L-tryptophan (L-Trp) and afforded ACE-βCs. MGO and ACE-βCs appeared in cultures from Escherichia coli and Lactilactobacillus sakei but not in cultures from other lactobacilli (L. plantarum, L. rhamnosus, and L. paracasei). Those bacteria producing MGO contained the enzyme methylglyoxal synthase (MgsA). MgsA was needed for the production of MGO as demonstrated by expressing the mgsA gene from L. sakei DSM 15831 T into Lacticaseibacillus paracasei BL23, and the recombinant strain produced MGO. The factors involved in the bacterial production of MGO are highlighted. E. coli produced MGO only in presence of glucose and L. sakei on galactose. The bacterial production of MGO (and resultant ACE-βCs) increased with the concentration of carbohydrates (glucose or galactose). The production of MGO from glucose in E. coli highly increased when phosphate was added and higher levels were produced under anaerobic or oxygen-limited conditions than in aerobic conditions. The results suggest that E coli may produce MGO under gut conditions and MGO may result from the accumulation of phosphorylated intermediates in glycolysis. It is concluded that bacteria possessing MgsA present in foods and human gut microbiota produce MGO that leads to the formation of ACE-βCs alkaloids. Bacterial production of MGO is relevant owing to its reactive and toxic nature whereas ACE-βCs are bioactive substances investigated in different targets., The authors thank the Agencia Estatal de Investigación (MCIN/AEI/https://doi.org/10.13039/501100011033) fur funding through the project PID2022-136438OB-I00 (funded by Recovery and Resilience Facility, RRF, NextGenerationEU) and projects PID-2021-123291OB-I00 and PID2021-127833OB-I00 (co-funded by the European Regional Development Fund. ERDF, “A way to build Europe”)., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Direct amidinium-phosphate interactions guide AT-selective DNA binding by a potent antileishmanial drug

  • Nué-Martinez, Jorge Jonathan
  • Ugedo, Cristina
  • Lagartera, Laura
  • Cumella, José
  • Dardonville, Christophe
  • Garavís, Miguel
Neglected tropical diseases caused by kinetoplastid parasites remain a major global health challenge, with current chemotherapies offering limited efficacy and safety. JNII40 is a promising bis(pyridine-2-carboxamidine) ligand with potent antiparasitic activity and selectivity in vivo against Leishmania parasites. The compound specifically targets AT-rich regions of DNA, predominant in the mitochondrion of these parasites. We used NMR spectroscopy to determine the high-resolution structure of a DNA duplex containing four consecutive AT repeats in complex with JNII40. The structure reveals that JNII40 binds deeply into the DNA minor groove through a network of direct and water-mediated hydrogen bonds, including direct interactions between amidine protons and DNA phosphate oxygens. These contacts, supported by extensive intermolecular NOEs, explain the high affinity and sequence selectivity toward AT-rich regions observed by calorimetry and NMR. Restrained molecular dynamics simulations highlight the critical role of two ordered water molecules that bridge the ligand and DNA, preserving the geometry of the complex. Ligand insertion induces a noticeable narrowing of the minor groove. Altogether, these findings provide a structural framework for the rational drug design of selective DNA-targeting molecules against kinetoplastid parasites such as Leishmania., C.D. discloses support for the research of this work from the Spanish Ministry of Science and Innovation/Agencia Estatal de Investigación(MCIN/ AEI) through grants PDC2022-133269-I00, co-funded by the European Union NextGenerationEU/PRTR, and PID2022-136438OB-I00, co-funded by the European Regional Development Fund (ERDF). M.G. discloses support from the Ramón y Cajal Program (RYC2023-043599-I) and grant PID2023-146366NB-I00, both funded by MCIN/AEI. M.G. also acknowledges support from the CSIC Internationalization Program IF_ERC. C.U. discloses support from a Fundación Ramón Areces predoctoral fellowship. The remaining authors declare no relevant funding., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nitroindazolinone derivatives: assessing the impact of the nitro group location on the activity against Trypanosoma cruzi

  • Fonseca-Berzal, Cristina
  • França Da Silva, Cristiane
  • Bernardino Da Silva, Patrícia
  • Meuser Batista, Marcos
  • Gómez-Barrio, Alicia
  • Vela, Nerea
  • Arán, Vicente J.
  • Correia Soeiro, Maria De Nazaré
Inthelastdecades,different5-nitroindazole-basedcompoundshavebeensynthesizedandproposed as potential agents for treating the infection caused by Trypanosoma cruzi, i.e. Chagas disease. In previous works, the 1,2-disubstituted 5-nitroindazolinone system has been identified as a promising scaffold to design compounds, among which derivatives with a benzyl moietyat N-2standout.Now,wehavesynthesized4-,6-and7-nitroindazolin-3-ones(19–24), analogues of the previously studied 2-benzyl-1-methyl-5-nitroindazolinone (1) and 2-benzyl5-nitro-1-propylindazolinone (2), to explore the impact of the nitro group position on their trypanocidal activity. These 8 nitro derivatives were in silico predicted to have good oral bioavailability and no toxicity risks. In vitro assays over bloodstream trypomastigotes (Y strain, DTUTcII) showed animprovement in the lytic profile of 2-benzyl-1-propyl derivatives, when the NO2 group is moved to position 6 of the indazole ring: EC50 = 34.55 µM (23) versus EC50 > 50 µM (2, 22 and 24). Regarding the assays on amastigotes (Tulahuen strain, DTU TcVI), 4-, 6- and 7-nitroindazoles did not display better activity (EC50 from 3.82 to > 20 µM) than 5-nitroindazoles, with EC50 = 2.34 (1) and 3.03 µM (2). The lack of cytotoxicity over cardiac (CC50 > 200 µM) and L929 cells (CC50 > 170 µM) supports selective action, particularly of 5-nitroindazolinones towards intracellular forms: SI > 85.47 (1) and 56.53 (2). Altogether, data indicate that the anti-T. cruzi activity of 4-, 6- and 7-nitroindazolinones is not better than that of 1 and 2, not presenting significant advantages over these two 5-nitroindazolinones., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINEICO, SAF2015-66690-R), the National Council for Scientific and Technological Development of Brazil (CNPq, 301372/2015-2) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ, E02/2017). The Spanish Ministry of Science and Innovation (MICINN, PID2022-136438OB-I00) and the 911120 UCM Research Group ‘Epidemiología, Diagnóstico y Terapia Antiparasitaria’ are also acknowledged. M..N.C.S. is a research fellow of CNPq and CNE researcher., Peer reviewed
Docta Complutense
Publicación Artículo científico (JournalArticle)

A Mini-Review on Enhancing Solubility in Topical Hydrogel Formulations Using Solid Dispersion Technology for Poorly Water-Soluble Drugs

  • Dahma, Zaid
  • Álvarez Álvarez, Covadonga
  • Torre Iglesias, Paloma Marina De La
The solubility behavior of drugs is a critical factor in formulation development. Approximately 40–45% of new drugs face market entry challenges due to low water solubility. Enhancing drug bioavailability is thus essential in developing pharmaceutical dosage forms. Many biopharmaceutical class II and IV drugs are commonly prescribed to treat inflammations, infections, and pain from various pathologies. Their oral administration has several drawbacks, including significant first-pass liver effects, low bioavailability, and adverse gastrointestinal effects. Topical application has gained relevance due to its advantages in delivering drugs directly to the target site, avoiding gastrointestinal irritation, and increasing their effectiveness. However, topical hydrogel formulations with poorly water-soluble drugs face challenges related to the skin’s permeability. Therefore, preparing topical hydrogels using solid dispersions (SDs) is an effective strategy to enhance the dissolution rate of poorly soluble drugs, thereby improving their topical bioavailability. In this review, the concepts of SDs, topical delivery systems, and topical hydrogel formulations incorporating SDs, as well as their preparation methods, characterization, and applications, will be discussed.
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Development and characterization of a new oral antileishmanial bis(pyridine-2-carboxamidine) drug through innovative dissolution testing in biorelevant media combined with pharmacokinetic studies

  • Laguna, Almudena
  • Martínez Alonso, Borja
  • Guarnizo Herrero, Víctor|||0000-0001-9323-3388
  • Nué Martinez, J. Jonathan
  • Dardonville, Christophe
  • Torrado Durán, Santiago
  • Torrado Salmerón, Carlos Félix
Background/Objectives: Currently there are very few effective oral antileishmanial treatments. In this study we evaluated a new bis(pyridine-2-carboxamidine) antileishmanial drug (JNII40_base) and its hydrochloride salt (JNII40_HCl). Methods: The characterization studies performed allowed us to determine the crystallinity, hydration water, and presence of hydrogen bonds in these drugs. Different dissolution methods were employed to predict intestinal absorption. A high-performance liquid chromatography–mass spectrophotometry (HPLC-MS/MS) method was developed for the determination of JNII40 in plasma. Results: Pharmacokinetic studies in rats of JNII40_base at 100 and 20 mg/kg, and JNII40_HCl at 20 mg/kg, showed a non-linear pharmacokinetic at high doses. An innovative biorelevant medium of phosphate buffer pH 6.8 with polysorbate 80 at 0.6% (w/v) showed high concentration values for JNII40_base at 30 min, which predicts good intestinal absorption. These results were consistent with the bioavailability data, which exhibited a significant (p < 0.05) increase in maximum plasma concentration (Cmax) and a slight delay in time to maximum (Tmax) compared to JNII40_HCl. Furthermore, the sustained release of JNII40_base in this biorelevant media was related to high plasma concentration values at 24 h (C24h) observed in bioavailability studies. These plasma concentrations of JNII40_base were above the half-maximal inhibitory concentration (IC50) against promastigote and amastigote forms of Leishmania donovani, which is indicative of effectiveness and should reduce the occurrence of drug resistance during treatments. Conclusions: The bioavailability and pharmacokinetic data support the consideration of this drug for further in vivo studies as an oral antileishmanial treatment., Agencia Estatal de Investigación
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Topical meloxicam hydroxipropyl guar hydrogels based on low-substituted hydroxypropyl cellulose solid dispersions

  • Dahma, Zaid
  • Torrado Salmerón, Carlos Félix
  • Álvarez Álvarez, Covandonga
  • Guarnizo Herrero, Víctor|||0000-0001-9323-3388
  • Martínez Alonso, Borja
  • Torrado Durán, Guillermo|||0000-0002-8865-2083
  • Torrado Durán, Santiago
  • Torre Iglesias, Paloma de la
Meloxicam (MX) is a poorly water-soluble drug with severe gastrointestinal side effects. Topical hydrogel of hydroxypropyl guar (HPG) was formulated using a solid dispersion (SD) of MX with hydroxypropyl cellulose (LHPC) as an alternative to oral administration. The development of a solid dispersion with an adequate MX:LHPC ratio could increase the topical delivery of meloxicam. Solid dispersions showed high MX solubility values and were related to an increase in hydrophilicity. The drug/polymer and polymer/polymer interactions of solid dispersions within the HPG hydrogels were evaluated by SEM, DSC, FTIR, and viscosity studies. A porous structure was observed in the solid dispersion hydrogel MX:LHPC (1:2.5) and its higher viscosity was related to a high increase in hydrogen bonds among the –OH groups from LHPC and HPG with water molecules. In vitro drug release studies showed increases of 3.20 and 3.97-fold for hydrogels with MX:LHPC ratios of (1:1) and (1:2.5), respectively, at 2 h compared to hydrogel with pure MX. Finally, a fitting transition from zero to first-order model was observed for these hydrogels containing solid dispersions, while the n value of Korsmeyer–Peppas model indicated that release mechanism is governed by diffusion through an important relaxation of the polymer., Agencia Estatal de Investigación